Evidence map›Paper›PMID 36890227›Full record

ArticleNature2023

Macrophage fumarate hydratase restrains mtRNA-mediated interferon production.

Alexander Hooftman, Christian G Peace, Dylan G Ryan, Emily A Day, Ming Yang, Anne F McGettrick, Maureen Yin, Erica N Montano, Lihong Huo, Juliana E Toller-Kawahisa and 18 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 155 papers.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed
33.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

155 citing papers in PubMed, 207 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 9 institutions in 6 countries.

Alexander Hooftman *School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland. ahooftma@tcd.ie.ORCID 0000-0002-5412-4012
Christian G Peace *School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.ORCID 0000-0002-5390-6530
Dylan G Ryan *School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland. dr523@cam.ac.uk.ORCID 0000-0003-4553-9192
Emily A DaySchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.ORCID 0000-0003-3245-5715
Ming YangMRC Cancer Unit, University of Cambridge, Cambridge, UK.
Anne F McGettrickSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.ORCID 0000-0001-6887-7229
Maureen YinSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.ORCID 0000-0003-1451-9906
Erica N MontanoDivision of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Lihong HuoDivision of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Juliana E Toller-KawahisaSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Vincent ZecchiniMRC Cancer Unit, University of Cambridge, Cambridge, UK.
Tristram A J RyanSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.ORCID 0000-0003-0278-1878
Alfonso Bolado-CarrancioEdinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, UK.ORCID 0000-0003-2330-7489
Alva M CaseyMRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.ORCID 0000-0002-7242-3251
Hiran A PragMRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.ORCID 0000-0002-4753-8567
Ana S H CostaMRC Cancer Unit, University of Cambridge, Cambridge, UK.
Gabriela De Los SantosDivision of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Mariko IshimoriDivision of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Daniel J WallaceDivision of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Swamy VenuturupalliDivision of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Efterpi NikitopoulouMRC Cancer Unit, University of Cambridge, Cambridge, UK.
Norma FrizzellSchool of Medicine, University of South Carolina, Columbia, SC, USA.ORCID 0000-0002-5080-4176
Cecilia JohanssonNational Heart and Lung Institute, Imperial College London, London, UK.ORCID 0000-0002-6607-5000
Alexander Von KriegsheimEdinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-4952-8573
Michael P MurphyMRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.ORCID 0000-0003-1115-9618
Caroline JefferiesDivision of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Christian FrezzaMRC Cancer Unit, University of Cambridge, Cambridge, UK.ORCID 0000-0002-3293-7397
Luke A J O'NeillSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland. laoneill@tcd.ie.ORCID 0000-0002-4333-2748
Cedars-Sinai Medical Center · USTrinity College Dublin · IEUniversity of Cambridge · GBEdinburgh Cancer Research · GBUniversity of Cologne · DEImperial College London · GBTrinity College · CAUniversidade de São Paulo · BRUniversity of South Carolina · US

Funding

Sex and gender differences in lupus - intersection between immunometabolism, epigenetic remodeling and cardiac involvementR01AI164504 · NIAID · CEDARS-SINAI MEDICAL CENTER · PI JEFFERIES, CAROLINE · 2021 to 2024
$2.3M
Investigating Citric Acid Cycle Perturbations in Complex I Deficient Mitochondrial EncephalopathyR01NS126851 · NINDS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI FRIZZELL, NORMA · 2022 to 2025
$1.5M
Medical Research Council MC_UU_00015/3Medical Research Council MC_UU_12022/6Medical Research Council MR/V000659/1NIAID NIH HHS R01 AI164504NINDS NIH HHS R01 NS126851Wellcome Trust
6 · The paper itself

Abstract

Metabolic rewiring underlies the effector functions of macrophages

Indexed as

Fumarate HydrataseInterferon-betaMacrophagesMitochondriaRNA, MitochondrialArgininosuccinate SynthaseArgininosuccinic AcidAspartic AcidCell RespirationCytosolDEAD Box Protein 58FumaratesHumansInterferon-Induced Helicase, IFIH1LipopolysaccharidesLupus Erythematosus, SystemicArgininosuccinate SynthaseArgininosuccinic AcidAspartic AcidDEAD Box Protein 58Fumarate HydrataseFumaratesIFIH1 protein, humanInterferon-betaInterferon-Induced Helicase, IFIH1LipopolysaccharidesReceptors, ImmunologicRIGI protein, humanRNA, MitochondrialTLR7 protein, humanToll-Like Receptor 7

Identifiers

PMID36890227
PMCPMC10411300
OpenAlexW4323546612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.